19 studies were found.

1.		Completed	Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors Conditions: Cachexia; unspecified adult solid tumor, protocol specific; Quality of Life
2.		No longer recruiting	Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Conditions: Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
3.		No longer recruiting	Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme Condition: adult glioblastoma multiforme
4.		No longer recruiting	Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer Conditions: stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
5.		No longer recruiting	Combination Chemotherapy for Patients With Brain Cancer Conditions: adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
6.		Recruiting	Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Condition: Cancer
7.		Recruiting	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus Conditions: stage II esophageal cancer; stage III esophageal cancer; squamous cell carcinoma of the esophagus; Adenocarcinoma of the Esophagus
8.		Recruiting	Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma Conditions: Recurrent Melanoma; Stage IV Melanoma
9.		Recruiting	Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer Conditions: recurrent breast cancer; stage IV breast cancer
10.		Recruiting	Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Unresectable Brain Metastases From Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; brain metastases
11.		No longer recruiting	Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia Conditions: recurrent adult acute myeloid leukemia; secondary acute myeloid leukemia
12.		No longer recruiting	Phase I/II Study of Lepirudin in Patients with Recurrent or Extensive Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer; childhood thorax/respiratory cancer
13.		Recruiting	Radiation Therapy After Surgery in Treating Patients With Phyllodes Tumor of the Breast Conditions: breast cancer in situ; recurrent breast cancer; Phyllodes Tumor
14.		Completed	Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma Condition: leptomeningeal metastases
15.		No longer recruiting	Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
16.		Recruiting	Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy Conditions: adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
17.		Recruiting	UCN-01 and Cisplatin in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
18.		Recruiting	Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer
19.		Recruiting	Vaccine Therapy in Treating Patients With Relapsed or Refractory Stage III or Stage IV Melanoma Conditions: Recurrent Melanoma; stage III melanoma; Stage IV Melanoma